Cargando…
Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386660/ https://www.ncbi.nlm.nih.gov/pubmed/25722425 http://dx.doi.org/10.1093/neuonc/nov021 |
| _version_ | 1782365194432806912 |
|---|---|
| author | Han, Kelong Ren, Melanie Wick, Wolfgang Abrey, Lauren Das, Asha Jin, Jin Reardon, David A. |
| author_facet | Han, Kelong Ren, Melanie Wick, Wolfgang Abrey, Lauren Das, Asha Jin, Jin Reardon, David A. |
| author_sort | Han, Kelong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4386660 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43866602015-04-07 Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma Han, Kelong Ren, Melanie Wick, Wolfgang Abrey, Lauren Das, Asha Jin, Jin Reardon, David A. Neuro Oncol Letters to the Editor Oxford University Press 2015-05 2015-02-26 /pmc/articles/PMC4386660/ /pubmed/25722425 http://dx.doi.org/10.1093/neuonc/nov021 Text en © The Author(s) 2015. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letters to the Editor Han, Kelong Ren, Melanie Wick, Wolfgang Abrey, Lauren Das, Asha Jin, Jin Reardon, David A. Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma |
| title | Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma |
| title_full | Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma |
| title_fullStr | Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma |
| title_full_unstemmed | Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma |
| title_short | Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma |
| title_sort | interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386660/ https://www.ncbi.nlm.nih.gov/pubmed/25722425 http://dx.doi.org/10.1093/neuonc/nov021 |
| work_keys_str_mv | AT hankelong interpretationofmetaanalysisevaluatingprogressionfreesurvivalasasurrogateendpointforoverallsurvivalinglioblastoma AT renmelanie interpretationofmetaanalysisevaluatingprogressionfreesurvivalasasurrogateendpointforoverallsurvivalinglioblastoma AT wickwolfgang interpretationofmetaanalysisevaluatingprogressionfreesurvivalasasurrogateendpointforoverallsurvivalinglioblastoma AT abreylauren interpretationofmetaanalysisevaluatingprogressionfreesurvivalasasurrogateendpointforoverallsurvivalinglioblastoma AT dasasha interpretationofmetaanalysisevaluatingprogressionfreesurvivalasasurrogateendpointforoverallsurvivalinglioblastoma AT jinjin interpretationofmetaanalysisevaluatingprogressionfreesurvivalasasurrogateendpointforoverallsurvivalinglioblastoma AT reardondavida interpretationofmetaanalysisevaluatingprogressionfreesurvivalasasurrogateendpointforoverallsurvivalinglioblastoma |